How can we use AI to uncover hidden health clues and allocate resources more effectively?
Hannah Li on the AI-driven early warning systems helping healthcare providers triage
Sandra Matz on three things generative AI can teach us about mental health
Jing Dong on the tools that can optimize resource allocation in hospitals
“If you think about the potential of generative AI to really fill in the gaps for people who don’t otherwise have support, there’s enormous potential.”
Sandra Matz
At its core, AVO leverages AI to process patient data directly from the Electronic Health Record (EHR), maps that data against clinical best practices, and produces "copilots" that automate clinician workflows.
Research shows that up to half of dementias may be preventable by addressing modifiable risk factors. These programs are typically delivered in person, are resource-intensive, and reach only a small fraction of the people who could benefit.
Pearl Health was founded to empower independent physicians through data and value-based care. The founding vision of Pearl Health—empowering independent physicians through data and value-based care—has only accelerated with the advent of AI.
In healthcare, accountability is non-negotiable, and the cost of mistakes is human life. How do we establish the policy, liability, and governance frameworks needed for safe and trustworthy human-AI collaboration?
Tianyi Peng on how digital twins break from their human counterparts on vaccine sentiment
Xuelin Li talks about governance structures needed to ensure responsible AI use in healthcare settings
“At the end of the day, we can’t trust AI just on its own, it’s always AI humans acting on some sort of AI knowledge.”
Hannah Li
AI has the potential to revolutionize mental health with crisis prediction and personalized care, but it also challenges workforce well-being. Balancing innovation with empathy is key.
“If we spend less time scrolling and more time talking to AI, what does that mean for our mental health? Will AI become a new form of dependency?"
Dante Donati
From intimate chats with founders to discussions with industry leaders, AI+ Healthcare hosts numerous events throughout the year.
New AI-based screening tools could help people who are falling through the cracks.
Columbia researchers are using AI to unravel genetic mysteries behind cancer, Alzheimer’s, and more.
New open-source software could shed light on how brain diseases work
Radiologists explains how AI, screening advances, and patient choice are reshaping breast cancer care.
Envisioning how artificial intelligence (AI) could usher in a new era for public health research.
GPT-4, large language model created by OpenAI, can accurately interpret types of cells important for the analysis of single-cell RNA sequencing—a sequencing process fundamental to interpreting cell types.
As Alzheimer’s disease begins to disrupt neurocognitive function, the symptoms can be so subtle that both family and loved ones struggle to discern the changes, delaying diagnosis even as damage compounds.
Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment of a number of neurological conditions.
Most scientists agree that categorizing an object — like thinking of a carrot as either a root vegetable or a party snack — is the job of the prefrontal cortex, the brain region responsible for reasoning and other high-level functions that make us smart and social. In that account, the eyes and visual regions of the brain are kind of like a security camera collecting data and processing it in a standardized way before passing it off for analysis.
When a person reaches for a cup of water, thousands of muscle signals fire in coordination. For stroke survivors, that seemingly effortless act can become impossible, and even the most advanced rehabilitation techniques have yet to fully restore this functionality.
Want to learn more about AI+Healthcare or the AI in Business Initiative? Reach out to us at aib@gsb.columbia.edu.
Learn more about CBS’s Healthcare and Pharmaceutical Management Program below.
The mission of Columbia Business School’s AI+Healthcare Initiative is to define the future of healthcare innovation, policy and delivery. Successfully leading the next period of healthcare transformation requires a clear vision of what’s possible–anchored by expertise in data, delivery and systems. We are on the forefront of that revolution, convening the experts and the thinkers who will transform the way we give and receive care, to drive collaboration and solutions.